FR2043475A1 - - Google Patents

Info

Publication number
FR2043475A1
FR2043475A1 FR6916297A FR6916297A FR2043475A1 FR 2043475 A1 FR2043475 A1 FR 2043475A1 FR 6916297 A FR6916297 A FR 6916297A FR 6916297 A FR6916297 A FR 6916297A FR 2043475 A1 FR2043475 A1 FR 2043475A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
FR6916297A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cassenne Laboratoires
Original Assignee
Cassenne Laboratoires
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to NLAANVRAGE7302132,A priority Critical patent/NL174267B/xx
Application filed by Cassenne Laboratoires filed Critical Cassenne Laboratoires
Priority to FR6916297A priority patent/FR2043475A1/fr
Priority to CH740770A priority patent/CH527272A/fr
Priority to ES379815A priority patent/ES379815A1/es
Priority to CA083247A priority patent/CA929476A/en
Priority to DE2024586A priority patent/DE2024586B2/de
Priority to NLAANVRAGE7007262,A priority patent/NL169754C/xx
Priority to SE7006905A priority patent/SE392904B/xx
Priority to BE750641D priority patent/BE750641A/fr
Priority to GB2447770A priority patent/GB1317027A/en
Priority to DK256770AA priority patent/DK129466B/da
Priority to HURO564A priority patent/HU162857B/hu
Publication of FR2043475A1 publication Critical patent/FR2043475A1/fr
Priority to US00330403A priority patent/US3855197A/en
Priority to US508335A priority patent/US3929994A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06—Lysis of microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/26—Klebsiella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
FR6916297A 1969-05-20 1969-05-20 Pending FR2043475A1 (fr)

Priority Applications (14)

Application Number Priority Date Filing Date Title
NLAANVRAGE7302132,A NL174267B (nl) 1969-05-20 Verbetering van de werkwijze voor de bereiding van een somatisch antigeen volgens het nederlandse octrooischrift 169754 en werkwijze ter bereiding van een farmaceutisch preparaat.
FR6916297A FR2043475A1 (fr) 1969-05-20 1969-05-20
CH740770A CH527272A (fr) 1969-05-20 1970-05-19 Procédé d'obtention de nouveaux composés d'origine bactérienne
ES379815A ES379815A1 (es) 1969-05-20 1970-05-19 Un procedimiento de preparacion de alfa-y beta-glicoprotei-nas lentas.
CA083247A CA929476A (en) 1969-05-20 1970-05-19 PROCEDE DE PREPARATION D'.alpha. ET .beta.-GLYCOPROTEINES LENTES
SE7006905A SE392904B (sv) 1969-05-20 1970-05-20 Sett att framstella alfa- eller beta-glykoproteiner med nonspecifikt antigena och anti-inflammatoriska egenskaper ur bakterier
NLAANVRAGE7007262,A NL169754C (nl) 1969-05-20 1970-05-20 Werkwijze voor de bereiding van een somatisch antigeen, alsmede van een farmaceutisch preparaat dat dit bevat.
DE2024586A DE2024586B2 (de) 1969-05-20 1970-05-20 Langsame a - und ß - Glykoproteine aus Mikrobenkörpern, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzung
BE750641D BE750641A (fr) 1969-05-20 1970-05-20 Nouveaux composes d'origine bacterienne et procede d'obtention
GB2447770A GB1317027A (en) 1969-05-20 1970-05-20 Proteins
DK256770AA DK129466B (da) 1969-05-20 1970-05-20 Fremgangsmåde til fremstilling af langsomme α- og β-glycoproteiner.
HURO564A HU162857B (fr) 1969-05-20 1970-05-20
US00330403A US3855197A (en) 1969-05-20 1973-02-07 Glycoproteins extracted from microorganisms
US508335A US3929994A (en) 1969-05-20 1974-09-23 Anti-inflammatory glycoprotein compositions and method of use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR6916297A FR2043475A1 (fr) 1969-05-20 1969-05-20

Publications (1)

Publication Number Publication Date
FR2043475A1 true FR2043475A1 (fr) 1971-02-19

Family

ID=9034297

Family Applications (1)

Application Number Title Priority Date Filing Date
FR6916297A Pending FR2043475A1 (fr) 1969-05-20 1969-05-20

Country Status (11)

Country Link
BE (1) BE750641A (fr)
CA (1) CA929476A (fr)
CH (1) CH527272A (fr)
DE (1) DE2024586B2 (fr)
DK (1) DK129466B (fr)
ES (1) ES379815A1 (fr)
FR (1) FR2043475A1 (fr)
GB (1) GB1317027A (fr)
HU (1) HU162857B (fr)
NL (2) NL169754C (fr)
SE (1) SE392904B (fr)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2845745A1 (de) * 1977-10-28 1979-05-10 American Cyanamid Co Kombinationsvaccine
EP0001945A1 (fr) * 1977-10-27 1979-05-16 Roussel-Uclaf Nouveaux polysaccharides extraits de corps microbiens d'Haemophilus Influenzae, leur procédé de préparation et les compositions pharmaceutiques les renfermant
FR2426470A1 (fr) * 1978-05-26 1979-12-21 Om Lab Sa Medicament immunobiotherapique contre des maladies infectieuses des voies respiratoires
FR2452288A1 (fr) * 1979-03-29 1980-10-24 Wellcome Found Antigene glycoproteique, sa preparation et vaccin contenant cet antigene
FR2462477A1 (fr) * 1979-07-31 1981-02-13 Cassenne Lab Sa Nouvelles glycoproteines de klebsiella pneumoniae, procede d'obtention, application a titre de medicaments et compositions les renfermant
FR2490495A1 (fr) * 1980-09-19 1982-03-26 Roussel Uclaf Nouvelles glycoproteines hydrosolubles immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
EP0049182A1 (fr) * 1980-09-19 1982-04-07 Roussel-Uclaf Nouvelles glycoprotéines immunostimulantes extraites de Klebsiella Pneumoniae, leur procédé d'obtention, leur application à titre de médicaments et les compositions les renfermant
EP0090660A2 (fr) * 1982-03-30 1983-10-05 THE UNITED STATES OF AMERICA as represented by the Secretary of The United States Department of Commerce Vaccin anti-gonococcique
FR2574429A1 (fr) * 1984-12-06 1986-06-13 Roussel Uclaf Acylglycannes extraits de klebsiella, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
EP0291294A1 (fr) * 1987-05-11 1988-11-17 Schering Corporation Extraction du facteur de stimulation de colonies de granulocytes macrophages de bactéries
GB2237740A (en) * 1989-10-17 1991-05-15 Roussel Uclaf Hair treatment compositions containing glycoprotein extracts of gram (-) bacteria
EP0552571A1 (fr) * 1992-01-09 1993-07-28 Becton, Dickinson and Company Libération de composés intracellulaires
EP0556521A1 (fr) * 1992-01-09 1993-08-25 Becton, Dickinson and Company Traitement d'un échantillon à l'aide d'un désinfectant

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2253499B1 (fr) * 1973-12-10 1977-11-04 Fabre Sa Pierre

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0001945A1 (fr) * 1977-10-27 1979-05-16 Roussel-Uclaf Nouveaux polysaccharides extraits de corps microbiens d'Haemophilus Influenzae, leur procédé de préparation et les compositions pharmaceutiques les renfermant
FR2407262A1 (fr) * 1977-10-27 1979-05-25 Cassenne Lab Sa Nouveaux polysaccharides extraits de corps microbiens d'haemophilus influenzae, procede de preparation et application a titre de medicaments de ces nouveaux produits
DE2845745A1 (de) * 1977-10-28 1979-05-10 American Cyanamid Co Kombinationsvaccine
FR2426470A1 (fr) * 1978-05-26 1979-12-21 Om Lab Sa Medicament immunobiotherapique contre des maladies infectieuses des voies respiratoires
FR2452288A1 (fr) * 1979-03-29 1980-10-24 Wellcome Found Antigene glycoproteique, sa preparation et vaccin contenant cet antigene
FR2462477A1 (fr) * 1979-07-31 1981-02-13 Cassenne Lab Sa Nouvelles glycoproteines de klebsiella pneumoniae, procede d'obtention, application a titre de medicaments et compositions les renfermant
FR2490495A1 (fr) * 1980-09-19 1982-03-26 Roussel Uclaf Nouvelles glycoproteines hydrosolubles immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
EP0049182A1 (fr) * 1980-09-19 1982-04-07 Roussel-Uclaf Nouvelles glycoprotéines immunostimulantes extraites de Klebsiella Pneumoniae, leur procédé d'obtention, leur application à titre de médicaments et les compositions les renfermant
EP0049181A1 (fr) * 1980-09-19 1982-04-07 Roussel-Uclaf Nouvelles glycoprotéines hydrosolubles immunostimulantes, extraites de Klebsiella Pneumoniae, leur procédé d'obtention, leur application à titre de médicaments et les compositions les renfermant
EP0090660A3 (fr) * 1982-03-30 1983-11-23 THE UNITED STATES OF AMERICA as represented by the Secretary of The United States Department of Commerce Vaccin anti-gonococcique
EP0090660A2 (fr) * 1982-03-30 1983-10-05 THE UNITED STATES OF AMERICA as represented by the Secretary of The United States Department of Commerce Vaccin anti-gonococcique
FR2574429A1 (fr) * 1984-12-06 1986-06-13 Roussel Uclaf Acylglycannes extraits de klebsiella, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
DE3543267A1 (de) * 1984-12-06 1986-08-28 Roussel-Uclaf, Paris Acylglykan-extrakte von klebsiella, deren gewinnungsverfahren, deren verwendung als arzneimittel und die sie enthaltenden zusammensetzungen
US4751218A (en) * 1984-12-06 1988-06-14 Roussel Uclaf Acylglycan extracts of Klebsiella
EP0291294A1 (fr) * 1987-05-11 1988-11-17 Schering Corporation Extraction du facteur de stimulation de colonies de granulocytes macrophages de bactéries
WO1988008881A1 (fr) * 1987-05-11 1988-11-17 Schering Corporation Extraction a partir de bacteries d'un facteur stimulant les colonies de granulocytes macrophages
US5136024A (en) * 1987-05-11 1992-08-04 Schering Corporation Extraction of granulocyte macrophage colony stimulating factor from bacteria
GB2237740A (en) * 1989-10-17 1991-05-15 Roussel Uclaf Hair treatment compositions containing glycoprotein extracts of gram (-) bacteria
GB2237740B (en) * 1989-10-17 1994-04-13 Roussel Uclaf Use of compositions containing glycoprotein extracts of gram (-) bacteria for the stimulation of hair growth
DE4032972C2 (de) * 1989-10-17 2000-07-13 Boots Co Plc Nottingham Verwendung von aus gramnegativen Bakterien extrahierten Glykoproteinen in kosmetischen oder dermatologischen Zusammensetzungen
EP0552571A1 (fr) * 1992-01-09 1993-07-28 Becton, Dickinson and Company Libération de composés intracellulaires
EP0556521A1 (fr) * 1992-01-09 1993-08-25 Becton, Dickinson and Company Traitement d'un échantillon à l'aide d'un désinfectant

Also Published As

Publication number Publication date
CH527272A (fr) 1972-08-31
NL7007262A (fr) 1970-11-24
DK129466C (fr) 1975-03-10
DK129466B (da) 1974-10-14
ES379815A1 (es) 1972-09-01
NL174267B (nl)
SE392904B (sv) 1977-04-25
DE2024586B2 (de) 1979-06-07
BE750641A (fr) 1970-11-20
NL169754C (nl) 1982-08-16
HU162857B (fr) 1973-04-28
CA929476A (en) 1973-07-03
DE2024586C3 (fr) 1980-02-14
NL169754B (nl) 1982-03-16
DE2024586A1 (de) 1970-11-26
GB1317027A (en) 1973-05-16

Similar Documents

Publication Publication Date Title
AU465452B2 (fr)
DK129466C (fr)
AU450150B2 (fr)
AU470301B1 (fr)
AU5113869A (fr)
AU442554B2 (fr)
AU442538B2 (fr)
AU442535B2 (fr)
AU442463B2 (fr)
AT308690B (fr)
AU470661B1 (fr)
CS149303B1 (fr)
CS148839B1 (fr)
AR203167Q (fr)
AU4949169A (fr)
AU5077469A (fr)
AU4540468A (fr)
AU5109569A (fr)
BE741388A (fr)
AU481328A (fr)
BE741090A (fr)
BE743538A (fr)
BE743610A (fr)
BE753037A (fr)
AU5066368A (fr)